Cbsaustin
Published November 13, 2026 · Updated November 15, 2026
US offers up to $4.9 million to prepare PTSD studies of controversial psychedelic drug
Read the full story at Cbsaustin
Three applications for psychedelic medicines, including potential drugs derived from psilocybin and MDMA, are pending review at the Food and Drug.
Surfaced by this Google Alert
- Psychedelics south america